These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 18804140

  • 1. Improved cell mediated immune responses after successful re-vaccination of non-responders to the hepatitis B virus surface antigen (HBsAg) vaccine using the combined hepatitis A and B vaccine.
    Nyström J, Cardell K, Björnsdottir TB, Fryden A, Hultgren C, Sällberg M.
    Vaccine; 2008 Nov 05; 26(47):5967-72. PubMed ID: 18804140
    [Abstract] [Full Text] [Related]

  • 2. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY, Chang MH, Hsieh RP, Ni YH, Chi WK.
    Hepatology; 1996 Dec 05; 24(6):1355-60. PubMed ID: 8938161
    [Abstract] [Full Text] [Related]

  • 3. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma.
    Böcher WO, Herzog-Hauff S, Schlaak J, Meyer zum Büschenfeld KH, Löhr HF.
    Hepatology; 1999 Jan 05; 29(1):238-44. PubMed ID: 9862872
    [Abstract] [Full Text] [Related]

  • 4. Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen.
    Rahman F, Dahmen A, Herzog-Hauff S, Böcher WO, Galle PR, Löhr HF.
    Hepatology; 2000 Feb 05; 31(2):521-7. PubMed ID: 10655280
    [Abstract] [Full Text] [Related]

  • 5. Antibody persistence and immune memory elicited by combined hepatitis A and B vaccination in older adults.
    Höhler T, Groeger-Bicanic G, Hoet B, Stoffel M.
    Vaccine; 2007 Feb 09; 25(8):1503-8. PubMed ID: 17097774
    [Abstract] [Full Text] [Related]

  • 6. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
    Duval B, Gîlca V, Boulianne N, Deceuninck G, Rochette L, De Serres G.
    Vaccine; 2005 Jul 01; 23(31):4082-7. PubMed ID: 15963363
    [Abstract] [Full Text] [Related]

  • 7. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells.
    Bauer T, Günther M, Bienzle U, Neuhaus R, Jilg W.
    Liver Transpl; 2007 Mar 01; 13(3):434-42. PubMed ID: 17318860
    [Abstract] [Full Text] [Related]

  • 8. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
    Zhao YL, Chen YG, Li J, Han GX, Tian C, Liang JL, Li G, Wang ZG, Zhu YG, Tian ZN, Zhang HY, Wan ZJ, Liang ZL, Bi SL.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun 01; 25(6):470-3. PubMed ID: 15231119
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination.
    Bauer T, Jilg W.
    Vaccine; 2006 Jan 30; 24(5):572-7. PubMed ID: 16171909
    [Abstract] [Full Text] [Related]

  • 10. [Reciprocal priming-boosting role of HBsAg and DNA vaccines].
    Zhou Z, Chen WS, Zhang HH, Yao JL.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr 30; 11(4):212-4. PubMed ID: 12716517
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens.
    Couillin I, Pol S, Mancini M, Driss F, Bréchot C, Tiollais P, Michel ML.
    J Infect Dis; 1999 Jul 30; 180(1):15-26. PubMed ID: 10353856
    [Abstract] [Full Text] [Related]

  • 15. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R, Smetana J, Sindelár R, Cecetková B, Prymula R, Kohl I.
    Epidemiol Mikrobiol Imunol; 2007 Aug 30; 56(3):119-28. PubMed ID: 17900060
    [Abstract] [Full Text] [Related]

  • 16. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
    Carniel EF, Morcillo AM, Blotta MH, Da Silva MT, Mazzola TN, Antonio MA, Zanolli ML, Netto AA, Higashi HG, Raw I, Vilela MM.
    Vaccine; 2008 Jan 30; 26(5):647-52. PubMed ID: 18155811
    [Abstract] [Full Text] [Related]

  • 17. Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen.
    Song ES, Park SA, Kim SH, Cho YJ, Ahn BY, Ahn BC, Lee NG.
    FEMS Immunol Med Microbiol; 2007 Dec 30; 51(3):496-504. PubMed ID: 17877731
    [Abstract] [Full Text] [Related]

  • 18. [Cellular immune responses of recombinant hepatitis B (rHB) vaccine and HBsAG derived from Hansenula polymorpha cells].
    Hu ZY, He P, Zhang R, Fang X, Zhu FC, Qiu SH, Li HM, Wang H, Liang ZL, Zhuang H.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jul 30; 29(7):706-11. PubMed ID: 19031766
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.